Katherine Hanson, clinical psychologist with Endeavor Health in Naperville, explains postpartum psychosis diagnoses.

Researchers used smartphone and wearable accelerometers to examine how everyday movement patterns relate to anxiety and ...

New Drug Application for azetukalner in focal seizures submitted to U.S. Food and Drug Administration; X-TOLE3 and X-ACKT continue to enroll focal seizure and PGTCS patients, respectively The Company ...

The church needs to get better at talking about mental health issues (including depression, bipolar disorder, and anxiety) ...

A new genetic study reveals that activating the GLP-1 receptor—the target of popular weight-loss drugs—is associated with a lower risk of depression and bipolar disorder, suggesting profound ...

New evidence shows GLP-1s are safe and potentially life-extending for patients with complex psychiatric histories. Here is how to translate the research into clear, effective conversations.

Grace Point Treatment Center has published a new educational resource examining why substance use disorders and mental health conditions often need to be assessed and treated together. The article, “ ...

Louise Barnett was 32 years old, standing at an overpass above the Dallas North Tollway with her toddler daughter at her side ...

Hosted by series creator Dr. Jeffrey Borenstein, President and CEO of the Brain & Behavior Research Foundation, Healthy Minds brings together leading researchers, clinicians, and people living with ...

Postpartum psychosis is a rare, clinically dramatic disorder typically beginning within a few weeks of delivery. Recent ...

Although we are born with a fixed number of brain cells, our brains continue to form new connections - or synapses - ...

LifeStance Health reports that postpartum psychosis, a rare but severe condition, is often misdiagnosed due to its unusual ...